Drugplain

SSKI 1 g/mL

Potassium Iodide · SOLUTION · Avondale Pharmaceuticals, LLC

No Recall HistoryCurrently in Shortage
Plain English

SSKI is a solution containing potassium iodide at 1 g/mL, taken oral. Manufactured by Avondale Pharmaceuticals, LLC.

Key Facts

Brand Name
SSKI
Generic Name
Potassium Iodide
NDC Code (Product)
71740-112
Manufacturer
Avondale Pharmaceuticals, LLC
Strength
1 g/mL
Dosage Form
SOLUTION
Route
ORAL
Marketing Status
Marketing Start
11/13/2017

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

diarrhoea273 reports
dyspnoea258 reports
sepsis255 reports
haemorrhagic stroke253 reports
fatigue248 reports
headache245 reports
fall244 reports
tachycardia240 reports
cardio-respiratory arrest239 reports
insomnia239 reports

Full Prescribing Information

Source: FDA Drug Label (SPL)For healthcare professionals

Indications & Usage

Indications and Usage SSKI ® (potassium iodide oral solution, USP) is for use as an expectorant in the symptomatic treatment of chronic pulmonary diseases where tenacious mucus complicates the problem, including bronchial asthma, bronchitis and pulmonary emphysema.

Dosage & Administration

Dosage and Administration Adults 0.3 ml (300 mg) or 0.6 ml (600 mg) diluted in one glassful of water, fruit juice or milk 3 to 4 times daily. To minimize gastric irritation, take with food or milk. This medication should be used no longer than necessary to produce the desired effect.

Warnings

Warnings Potassium iodide can cause fetal harm, abnormal thyroid function, and goiter when administered to a pregnant woman. Because of the possible development of fetal goiter, if the drug is used during pregnancy or if the patient becomes pregnant during therapy, apprise the patient of the potential hazard.

Contraindications

Contraindications Contraindicated in patients with a known sensitivity to iodides.

Drug Interactions

Drug Interactions Concurrent use with lithium or antithyroid drugs may potentiate the hypothyroid and goitrogenic effects of these medications. Concurrent use with potassium-containing medications, potassium-sparing diuretics and angiotensin-converting enzyme inhibitors (ACE inhibitors) may result in hyperkalemia and cardiac arrhythmias or cardiac arrest.

Adverse Reactions

Adverse Reactions The most frequent adverse reactions to potassium iodide are stomach upset, diarrhea, nausea, vomiting, stomach pain, skin rash, and salivary gland swelling or tenderness. Less frequent adverse reactions include gastrointestinal bleeding, confusion, irregular heartbeat, numbness, tingling, pain or weakness in hands or feet, unusual tiredness, weakness or heaviness of legs, fever, and swelling of neck or throat. Thyroid adenoma, goiter, and myxedema are possible side effects. Iodism or chronic iodine poisoning may occur during prolonged treatment or with the use of high doses. The symptoms of iodism include burning of mouth or throat, severe headache, metallic taste, soreness of teeth and gums, symptoms of head cold, irritation of the eyes with swelling of the eyelids, unusual increase in salivation, acneform skin lesions in the seborrheic areas, and rarely, severe skin eruptions. If symptoms of iodism appear, the drug should be withdrawn and the patient given appropriate supportive therapy. Hypersensitivity to iodides may occur and may be manifested by angioedema, cutaneous and mucosal hemorrhage, and signs and symptoms resembling serum sickness, such as fever, art

Frequently Asked Questions

What is SSKI used for?

SSKI contains Potassium Iodide. It is a solution taken oral. Consult your doctor for specific uses.

Is SSKI a controlled substance?

SSKI is not classified as a controlled substance by the DEA.

What is the generic name for SSKI?

The generic name for SSKI is Potassium Iodide. There are 11 other brand versions of Potassium Iodide.

What is the NDC code for SSKI 1 g/mL?

The NDC (National Drug Code) for SSKI 1 g/mL is 71740-112, listed by Avondale Pharmaceuticals, LLC.